Search Result "5-hydroxytryptamine<sub>2A</sub> receptor"
When is a Proof-of-Concept (POC) not a POC? Pomaglumetad (LY2140023) as a Case Study for Antipsychotic Efficacy
Journal: Current Pharmaceutical Design
Volume: 21 Issue: 26 Year: 2015 Page: 3788-3796
Author(s): Gerard J. Marek
Signal Transduction Abnormalities in Suicide: Focus on Phosphoinositide Signaling System
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 12 Issue: 7 Year: 2013 Page: 941-953
Author(s): Ghanshyam N. Pandey
Indolealkylamines from Toad Vertebrates and Sea Invertebrates - Their Identification and Potential Activities on the Central Nervous System
Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 16 Issue: 3 Year: 2016 Page: 197-207
Author(s): Abu Hasanat Md. Zulfiker,Gian Luigi Mariottini,Ji Qi,I. Darren Grice,Ming Q. Wei
The Potential of Trace Amines and Their Receptors for Treating Neurological and Psychiatric Diseases
Journal: Reviews on Recent Clinical Trials
Volume: 2 Issue: 1 Year: 2007 Page: 3-19
Author(s): M. D. Berry
Drug Design of GPCR Ligands Using Physicogenetics and Chemogenomics - Principles and Case Studies
Journal: Current Topics in Medicinal Chemistry
Volume: 11 Issue: 1 Year: 2011 Page: 1882-1901
Author(s): Thomas M. Frimurer, Thomas Hogberg
Pharmacogenetics in Geriatric Medicine: Challenges and Opportunities for Clinical Practice
Journal: Current Drug Metabolism
Volume: 12 Issue: 7 Year: 2011 Page: 621-634
Author(s): Alberto Pilotto, Francesco Panza, Davide Seripa
Animal Models of Depressive Illness: The Importance of Chronic Drug Treatment
Journal: Current Pharmaceutical Design
Volume: 11 Issue: 2 Year: 2005 Page: 171-203
Author(s): P. J. Mitchell, P. H. Redfern